Evidence map›Paper›PMID 22550537›Full record

ReviewClinical & developmental immunology2012

Suboptimal immune reconstitution in vertically HIV infected children: a view on how HIV replication and timing of HAART initiation can impact on T and B-cell compartment.

Nicola Cotugno, Iyadh Douagi, Paolo Rossi, Paolo Palma

Abstract readReview
In one paragraph

Review in Clinical & developmental immunology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Artificial Intelligence Applied toFrontiers in immunology · 2020
    Article
  12. Review
  13. Review
  14. Review
  15. Induction ofJournal of immunology (Baltimore, Md. : 1950) · 2017
    Article
  16. Article
  17. Article
  18. Recent Thymus Emigrant CD4+ T Cells Predict HIV Disease Progression in Patients With Perinatally Acquired HIV.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2016
    Article
  19. Immune activation and paediatric HIV-1 disease outcome.Current opinion in HIV and AIDS · 2016
    Review
  20. Prevalence and Persistence of Varicella Antibodies in Previously Immunized Children and Youth With Perinatal HIV-1 Infection.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nicola CotugnoUniversity of Rome, Tor Vergata, 00133 Rome, Italy.
Iyadh Douagi
Paolo Rossi
Paolo Palma

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Today, HIV-infected children who have access to treatment face a chronic rather than a progressive and fatal disease. As a result, new challenges are emerging in the field. Recent lines of evidence outline several factors that can differently affect the ability of the immune system to fully reconstitute and to mount specific immune responses in children receiving HAART. In this paper, we review the underlying mechanisms of immune reconstitution after HAART initiation among vertically HIV-infected children analyzing the possible causes of suboptimal responses.

Indexed as

Anti-HIV AgentsAntiretroviral Therapy, Highly ActiveB-LymphocytesCD4 Lymphocyte CountChildCytokinesFemaleHIVHIV InfectionsHumansInfectious Disease Transmission, VerticalTime FactorsT-LymphocytesViral LoadVirus ReplicationAnti-HIV AgentsCytokines

Identifiers

PMID22550537
PMCPMC3328919

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.